Table 5.
LFC
|
DM
|
OR (95%CI, P value)
|
OR (95%CI, P value)
|
Male | Unadjusted | After adjusted | |
Q1 (n = 389) | 82 (21.1) | 0.635 (0.504-0.799, < 0.001) | 0.308 (0.102-0.932, 0.032) |
Q2 (n = 350) | 66 (18.8) | 0.540 (0.416-0.700, < 0.001) | 0.184 (0.049-0.685, 0.012) |
Q3 (n = 306) | 74 (24.2) | 0.760 (0.599-0.963, 0.023) | 0.678 (0.158-2.908, 0.601) |
Q4(n = 325) | 116 (35.7) | 0.830 (0.665-1.035, 0.099) | 1.561 (0.440-5.539, 0.491) |
Female | |||
Q1 (n = 605) | 84 (13.9) | 0.828 (0.672-1.021, 0.077) | 0.964 (0.311-2.990, 0.949) |
Q2 (n = 642) | 92 (14.3) | 0.745 (0.609-0.913, 0.004) | 0.517 (0.170-1.578, 0.247) |
Q3 (n = 685) | 118 (17.2) | 0.739 (0.615-1.887, 0.091) | 0.750 (0.274-2.048, 0.574) |
Q4 (n = 667) | 210 (31.5) | 0.871 (0.750-1.011, 0.070) | 1.122 (0.445-2.830, 0.808) |
The quartiles of LFC were divided as follows: Q1: < 2.53%; Q2: ≥ 2.53%-< 5.52%; Q3: ≥ 5.52%- < 11.61%; Q4: ≥ 11.61%. Adjusted factors: Age, cigarette smoking, diabetes family history, FM, FM × ASM% quartiles, obesity, SBP, TG, HDL-C, and HOMA-IR. LFC: Liver fat content; DM: Diabetes mellitus; OR: Odds ratio; FM: Fat mass; ASM: Appendicular skeletal muscle mass; SBP: Systolic blood pressure; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; HOMA-IR: Homeostasis model assessment for insulin resistance.